EP3097081B1 - Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates - Google Patents

Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates Download PDF

Info

Publication number
EP3097081B1
EP3097081B1 EP15700749.3A EP15700749A EP3097081B1 EP 3097081 B1 EP3097081 B1 EP 3097081B1 EP 15700749 A EP15700749 A EP 15700749A EP 3097081 B1 EP3097081 B1 EP 3097081B1
Authority
EP
European Patent Office
Prior art keywords
alkyl
pyrazole
difluoromethyl
carbaldehydes
fluor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15700749.3A
Other languages
German (de)
French (fr)
Other versions
EP3097081A1 (en
Inventor
Norbert Lui
Sergii Pazenok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Priority to EP15700749.3A priority Critical patent/EP3097081B1/en
Publication of EP3097081A1 publication Critical patent/EP3097081A1/en
Application granted granted Critical
Publication of EP3097081B1 publication Critical patent/EP3097081B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles

Definitions

  • R 1 and R 3 are independently C1-C6-alkyl.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)

Description

  • The present invention relates to a novel method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1H-pyrazole-4-carbaldehydes or esters thereof of formula (I) by means of reductive dehalogenation, starting from 1-alkyl-3-chlorodifluoromethyl-5-fluoro-1H-pyrazole-4-carbaldehydes or esters thereof of formula (II)
    Figure imgb0001
     wherein R1 is C1-C6-alkyl and R is H or C1-C6-alkoxy.
  • 1-Alkyl-3-haloalkyl-5-fluoropyrazolecarbaldehydes and esters thereof are important building blocks for preparing plant protection active ingredients, particularly SDHI fungicides.
  • 1-Alkyl-3-difluoromethyl-5-fluor-1H-pyrazole-4-carbaldehydes was so far typically prepared in a multi-stage transformation starting from difluoromethylacetoacetate ( WO 2011061205 ) :
    Figure imgb0002
  • Starting material for this transformation, i.e.ethyldifluoracetoacetate, is a rather unstable compound, difficult to purify and which loses its quality during storage. This makes the utilization of this compound, especially on industrial scale, difficult.
  • The transformation of pyrazolic compounds bearing CF2H group is a challenging task as well, since this group is rather unstable under acidic conditions and easily releases fluoride which can damage reaction vessel, especially on a technical scale.
  • A process for the preparation of esters of 1-alkyl-3-fluoroalkylpyrazole-carboxylic acids via the reduction of 3-chlorodifluoromethylpyrazolic caboxylates was known from WO 2012/010692 . Nevertheless, it was not known nor expected that a reductive dehalogenation of CF2Cl-group can occur in pyrazoles bearing a halogen atom in position 5 or a carbaldehyde function in position 4 without undesirable effect on said halogen atom in position 5 or carbaldehyde function in position 4. On contrario, the skilled man would expect that the aldehyde group will also at least partially react, and/or that the fluorine atom in position 5 will also at least partially react, as it is shown or suggested in WO 2013/171134 and WO 2004/063165 . Indeed WO 2013/171134 shows the reductive elimination of the halogen atom in position 5 of 5-chloro-1-alkyl-3-difluormethylcarbaldehyde, and WO 2004/063165 describes the removal of a chlorine atom in N-aryl-3-methyl-5-chloropyrazole-carbaldehydes.
  • It has now surprisingly been found that, under the conditions of the invention, it is possible to selectively remove a halogen atom from a chlorodifluoromethyl group in 1-alkyl-3-chlorodifluoromethyl-5-fluoro-1H-pyrazole-4-carbaldehydes of formula (IIa) or 1-alkyl-3-chlorodifluoromethyl-5-fluor-1H-pyrazole-4-carboxylates of formula (IIb), without affecting or reducing the fluorine atom in position 5, without reducing the carbaldehyde or carboxylate group in position 4 and without attacking the pyrazole ring.
    It has also surprisingly been found that the reductive dehalogenation of 5-Fluoro-1-alkyl-3-chlorodifluoroalkyl-1H-pyrazole-4-carbaldehydes and esters thereof leads selectively and in high yield to the 1-alkyl-3-difluoromethyl- 5-fluoro-1H-pyrazole-4-carbaldehydes and esters thereof.
  • It has now been found that 1-alkyl-3-difluoromethyl -5-fluor-1H-pyrazole-4-carbaldehydes or esters thereof of formula (I)
    Figure imgb0003
     wherein R1 is C1-C6-alkyl and R is H or C1-C6-alkoxy,
    can be obtained by reacting 5-fluoro-1-alkyl-3-chlorodifluoromethyl -5-fluoro-1H-pyrazole-4-carbaldehydes or esters thereof of formula (II)
    Figure imgb0004
     wherein R and R1 are as stated above,
    by means of catalytic hydrogenation and optionally in the presence of a base.
  • It has now been found that 1-alkyl-3-difluoromethyl-1H-pyrazole-4-carbaldehydes of formula (Ia) or 1-alkyl-3-difluoromethyl-5-fluoro-1H-pyrazole-4-carboxylates of formula (Ib)
    Figure imgb0005
     where R1 is C1-C6-alkyl, and R2 is C1-C6-alkoxy,
    can be obtained by reacting 5-fluoro-1-alkyl-3-chlorodifluoromethyl -5-fluoro-1H-pyrazole-4-carbaldehydes of formula (IIa) or 1-alkyl-3-chlorodifluoromethyl-5-fluor-1H-pyrazole-4-carboxylates of formula (IIb) respectively
    Figure imgb0006
     where R1, R2 have the meanings stated above,
    by means of catalytic hydrogenation and optionally in the presence of a base.
  • The method according to the invention may be illustrated by the following formula schemes:
    Figure imgb0007
     or
    Figure imgb0008
     where R1 is C1-C6-alkyl, and R2 is C1-C6-alkoxy.
  • The radical R1 is preferably methyl, ethyl, n-propyl, isopropyl, butyl, pentyl, particularly preferably methyl or ethyl, even more preferably methyl.
    5-Fluoro-1-methyl-3-difluoromethyl-1H-pyrazole-4-carbaldehyde (II-1) or esters thereof and 5- Fluoro-1-ethyl-3-difluoromethyl-1H-pyrazole-4-carbaldehyde (II-2) or ester thereof are very particularly preferably used as starting material.
  • The reaction is carried out in the presence of hydrogen. It is possible to use either pure hydrogen or mixtures of hydrogen and an inert gas (up to 1 : 1), such as nitrogen or argon. The reaction is carried out at pressures of 1 bar to 50 bar, preferably 1 bar to 20 bar and particularly preferably 2 bar to 15 bar.
  • To scavenge the hydrogen chloride, formed during the reaction, a base is optionally added. As added base, either an inorganic base such as sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, mono-, di- or trisodium phosphate or tripotassium phosphate, sodium hydroxide or potassium hydroxide or an organic base such as triethylamine, tributylamine, diazabicycloundecene (DBU), diazabicyclononene (DBN), pyridine, lutidine, 2-, 3- or 4-picoline or diazabicyclooctane (DABCO) can be used. Preference is given to the use of triethylamine. 0.5 to 20 molar equivalents, preferably 0.5 to 5 molar equivalents and particularly preferably 1 to 5 molar equivalents of the base are added, based on the substrate.
  • In the catalytic hydrogenation for reducing the compound of the general formula (II), any hydrogenation catalyst may be used as catalyst. Suitable catalysts include optionally one or more metals from groups 8 - 10 of the periodic table on any conventional inorganic support. Examples include noble metal catalysts, such as ruthenium catalysts, palladium catalysts, platinum catalysts and rhodium catalysts, Raney nickel catalysts and Raney cobalt and Lindlar catalysts. In addition to these heterogeneous catalysts, hydrogenations over homogeneous catalysts can, however, also be carried out, for example over the Wilkinson catalyst. The relevant catalysts may be used in supported form, for example on carbon (charcoal or activated charcoal), aluminium oxide, silicon dioxide, zirconium dioxide, calcium carbonate or titanium dioxide. Catalysts of this kind are known per se to those skilled in the art. Particularly preferred are palladium catalysts supported on calcium carbonate. The catalysts may be used either in water-moist or in dried form. The catalyst used is preferably reused for a plurality of conversions. In the method according to the invention, the catalyst is used at a concentration of approximately 0.01 to approximately 30% by weight, based on the halo-1-alkyl-3-fluoroalkyl-1H-pyrazole-4-carbaldehyde of the formula (II) used. The catalyst is preferably used at a concentration of approximately 0.1 to approximately 5% by weight.
  • In the process according to the invention, the reduction is advantageously carried out in the presence of at least of one additive. Typical additives are, NH4OAc, Sodium Acetate, MgF2, NH4F, AlF3, K2CO3, Borax. Especially K2CO3, NH4Cl, NH4F, CsF or Borax.
  • The reaction time may be up to 20 hours, depending on the reactivity of the reactants, while the reaction can also be terminated earlier when conversion is complete. Preference is given to reaction times of 3-10 hours.
  • The reaction is carried out in the presence of a solvent. Suitable solvents are: alcohols, ethyl acetate, isopropyl acetate, THF, methyltetrahydrofuran, dioxane, toluene, hexane, heptane, pentane or petroleum ether. Particular preference is given to the use of methanol, ethanol, DMSO, dimethylacetamide, DMF or NMP.
  • 5-Fluoro-1-alkyl-3-chlorodifluoroalkyl-1H-pyrazole-4-carbaldehydes of the formula (IIa) can be prepared by known methods (cf. J. Het. Chem. 1990, 27, 243, WO 2006/018725 A1 , WO 2011/061205 A1 , B.Hamper et al. Journal of Organic Chemistry V.57,N21,5680-6, WO 2011061205 , WO2013171134 and WO2011131615 ).
  • The preparation of compounds could be performed according to the following schema.
    Figure imgb0009
     where R1 and R3 are independently C1-C6-alkyl.
    • Preparation examples Example 1 1-methyl-3-difluoromethyl-5-fluoro-1H-pyrazole-4-carbaldehyde .
  • Figure imgb0010
  • In an autoclave 10 g of 5 -fluoro-3 -(difluorochlormethyl)-1-methyl-1H-pyrazole-4-carbaldehyde dissolved in 150 ml of THF and 10 g triethylamin and 500 mg of 5 % palladium on calcium carbonate were added. The autoclave was flushed with nitrogen and pressurised to 15 bar hydrogen. Reaction mixture in autoclave was stirred at 90°C for 6 h. After filtration of the catalyst, the solvent was removed under reduced pressure and the product was obtained as a solid and purified via crystallization from mixture isopropanol/water. Yield 7 g , melting point 68-69°C
    • Example 2
  • In an autoclave 10 g of 5-chloro-3-(difluorochlormethyl)-1-methyl-1H-pyrazole-4-carbaldehyde dissolved in 150 ml of THF and 10 g CsF and 400 mg of 150 mg Pd(OH)2 on carbon were added. The autoclave was flushed with nitrogen and pressurised to 15 bar hydrogen. Reaction mixture in autoclave was stirred at 90°C for 6 h. After filtration of the catalyst, the solvent was removed under reduced pressure and the product was obtained as a solid and purified via crystallization from mixture isopropanol/water. Yield 7 g, melting point 68-69°C
    • Example 3. Ethyl 1-methyl-3-difluormethyl-5-fluoro-1H-pyrazole-4-carboxylate
  • Figure imgb0011
  • In an autoclave 10,5 g of Ethyl 1-methyl-3-chlorodifluormethyl-5-fluoro-1H-pyrazole-4-carboxylate in 100 ml of THF, 6 g Potassium carbonate and 150 mg Pd(OH)2 on carbon support were added. The autoclave was flushed with nitrogen and pressurised to 15 bar hydrogen. Reaction mixture in autoclave was stirred at 100°C for 6 h. After filtration of the catalyst, the solvent was removed under reduced pressure and the product was obtained as a solid and purified via crystallization from mixture isopropanol/water. Yield 7.2 g.

Claims (7)

  1. Process for preparing 1-alkyl-3-difluoromethyl -5-fluor-1H-pyrazole-4-carbaldehydes or esters thereof of formula (I)
    Figure imgb0012
    wherein R1 is C1-C6-alkyl and R is H or C1-C6-alkoxy,
    characterized in that
    5-fluoro-1-alkyl-3-chlorodifluoromethyl -5-fluoro-1H-pyrazole-4-carbaldehydes or esters thereof of formula (II)
    Figure imgb0013
     wherein R and R1 are as stated above,
    is reacted by means of catalytic hydrogenation.
  2. The process according to claim 1 wherein R1 is methyl, ethyl, n-propyl, isopropyl, butyl or pentyl.
  3. The process according to claim 2 wherein R1 is methyl or ethyl.
  4. The process according to claim 3 wherein R1 is methyl.
  5. The process according to any ones of claims 1 to 4 wherein the catalytic hydrogenation is done in presence of a base.
  6. The process according to claim 5 wherein the base is sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, mono-, di- or trisodium phosphate, tripotassium phosphate, sodium hydroxide, potassium hydroxide, triethylamine, tributylamine, diazabicycloundecene (DBU), diazabicyclononene (DBN), pyridine, lutidine, 2-, 3- or 4-picoline or diazabicyclooctane (DABCO).
  7. The process according to claim 5 wherein the base is triethylamine.
EP15700749.3A 2014-01-24 2015-01-22 Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates Active EP3097081B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15700749.3A EP3097081B1 (en) 2014-01-24 2015-01-22 Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14356001 2014-01-24
EP15700749.3A EP3097081B1 (en) 2014-01-24 2015-01-22 Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates
PCT/EP2015/051184 WO2015110493A1 (en) 2014-01-24 2015-01-22 Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates

Publications (2)

Publication Number Publication Date
EP3097081A1 EP3097081A1 (en) 2016-11-30
EP3097081B1 true EP3097081B1 (en) 2018-01-10

Family

ID=50073123

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15700749.3A Active EP3097081B1 (en) 2014-01-24 2015-01-22 Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates

Country Status (12)

Country Link
US (1) US9656966B2 (en)
EP (1) EP3097081B1 (en)
JP (1) JP6462703B2 (en)
KR (1) KR102319577B1 (en)
CN (1) CN105934430B (en)
BR (1) BR112016016397B1 (en)
DK (1) DK3097081T3 (en)
ES (1) ES2657424T3 (en)
IL (1) IL246870B (en)
MX (1) MX361770B (en)
TW (1) TWI628168B (en)
WO (1) WO2015110493A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109694350B (en) * 2017-10-20 2023-05-09 中国科学院上海有机化学研究所 Compound containing fluoromethyl and preparation method thereof
AR122756A1 (en) * 2020-07-02 2022-10-05 Pfizer PREPARATION OF A PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE DERIVATIVE AND SALT THEREOF
TWI782599B (en) * 2020-07-02 2022-11-01 美商輝瑞股份有限公司 Aminopyrimidinyl derivatives
WO2022233129A1 (en) 2021-05-05 2022-11-10 Fujian Yongjing Technology Co., Ltd New process for the synthesis of 5-fluoro-3- (difuoromethyl) -5-fluoro-1-methyl-1h-pyrazole-4-carboxylic acid derivatives and the free acid thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658962A (en) * 1994-05-20 1997-08-19 Minnesota Mining And Manufacturing Company Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
WO2004063166A1 (en) * 2003-01-06 2004-07-29 Eli Lilly And Company Heterocyclic ppar modulators
RS51794B (en) 2004-08-18 2011-12-31 Pfizer Inc. Inhibitors of hepatitis c virus rna-dependent rna polymerase, and and compositions and treatments using the same
GB0428137D0 (en) * 2004-12-22 2005-01-26 Syngenta Participations Ag Novel herbicides
DE102005009457A1 (en) * 2005-03-02 2006-09-07 Bayer Cropscience Ag Process for the preparation of alkylanilides
EP1721899A1 (en) * 2005-05-13 2006-11-15 Bayer CropScience S.A. Process for the preparation of a carboxamide derivative
WO2008006540A1 (en) * 2006-07-12 2008-01-17 Syngenta Participations Ag Triazolopyridine derivatives as herbicides
GB0813436D0 (en) * 2008-07-22 2008-08-27 Syngenta Participations Ag Insecticidal compounds
AR076839A1 (en) * 2009-05-15 2011-07-13 Bayer Cropscience Ag FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS
EP2325173A1 (en) * 2009-11-19 2011-05-25 Bayer CropScience AG Method for producing 5-fluor-1-alkyl-3-fluoralkyl-1H-pyrazol-4-carboxylic acid chlorides
KR101774966B1 (en) * 2010-04-23 2017-09-05 바이엘 인텔렉쳐 프로퍼티 게엠베하 Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbonyl chlorides and fluorides
US8981116B2 (en) 2010-07-23 2015-03-17 Solvay Sa Process for the preparation of esters of 1-substituted-3-fluoroalkyl-pyrazole-4-carboxylic acids
JP5854049B2 (en) * 2011-01-28 2016-02-09 日本電気株式会社 COMMUNICATION SYSTEM, CONTROL INFORMATION RELAY DEVICE, CONTROL DEVICE, CONTROL INFORMATION TRANSMISSION METHOD, AND PROGRAM
KR102006518B1 (en) * 2012-05-14 2019-08-01 바이엘 크롭사이언스 악티엔게젤샤프트 Process for preparing 1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carboxylic acid chlorides

Also Published As

Publication number Publication date
TWI628168B (en) 2018-07-01
WO2015110493A1 (en) 2015-07-30
KR20160111506A (en) 2016-09-26
US9656966B2 (en) 2017-05-23
JP2017506219A (en) 2017-03-02
DK3097081T3 (en) 2018-01-29
CN105934430B (en) 2018-03-16
MX361770B (en) 2018-12-17
BR112016016397A2 (en) 2018-12-26
CN105934430A (en) 2016-09-07
EP3097081A1 (en) 2016-11-30
JP6462703B2 (en) 2019-01-30
ES2657424T3 (en) 2018-03-05
KR102319577B1 (en) 2021-10-29
BR112016016397B1 (en) 2021-06-29
US20170008852A1 (en) 2017-01-12
MX2016009325A (en) 2016-10-13
IL246870B (en) 2018-03-29
TW201615625A (en) 2016-05-01

Similar Documents

Publication Publication Date Title
DK2734493T3 (en) METHOD OF PREPARING 2,2-DIFLUORETHANOL
EP3097081B1 (en) Method for preparing 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carbaldehydes and 1-alkyl-3-difluoromethyl-5-fluor-1h-pyrazole-4-carboxylates
EP3674285B1 (en) Process for producing m-xylylenediamine
JP6168044B2 (en) Method for producing tetrahydrofuran compound
TWI482749B (en) Process for preparing 2,2-difluoroethylamine and salts thereof proceeding from difluoroacetonitrile
JP2007091627A (en) Method for producing cyanopyridine derivative
JP4984676B2 (en) Preparation of aniline having benzyloxy group
JP5233299B2 (en) Method for purifying optically active 1- (2-trifluoromethylphenyl) ethanol
JP5507147B2 (en) Process for producing pyrimidinyl alcohol derivatives and synthetic intermediates thereof
AU2002214999B2 (en) Method for producing 1 substituted 5-chloro-4 methyl pyrazoles
US10233155B2 (en) Processes for the preparation of pesticide compounds
JP2008007503A (en) Method for producing 4-methylpyrazole-5-carboxylic ester
JP4896476B2 (en) Methyloxymethylaminopyridine derivative and method for producing the same
JP5797108B2 (en) 2-Indanol production method
JP6288101B2 (en) Synthesis of tetrahydromyrcenol
JP2004067592A (en) Method for producing aminophenylpiperidine
AU2019292883A1 (en) Method for producing α-azidoaniline derivative or α, α'-diazide derivative
JP2009035537A (en) Methods for producing n-substituted aniline derivative and 1-substituted indole derivative
JPH07145146A (en) Production of 4-ethyl-1,3-di(substituted phenyl) pyrrolidin-2-one derivative
JP2009256316A (en) METHOD FOR PRODUCING beta-HYDROXY-gamma-BUTYROLACTONE
JP2015063488A (en) Method of manufacturing 4-hydroxy-2-methylbenzoic acid derivative
JP2013216605A (en) Method of producing 3-difluoroalkyl pyrazole compound
JP2009286778A (en) Production method of tert-butyl 3-aminopiperidine-1-carboxylate and intermediate thereof
JP2002322128A (en) Method for producing benzyl derivative

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160824

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170803

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 962245

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180115

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20180123

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015007347

Country of ref document: DE

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2657424

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20180305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180410

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180411

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180510

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180410

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015007347

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180122

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

26N No opposition filed

Effective date: 20181011

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

REG Reference to a national code

Ref country code: AT

Ref legal event code: UEP

Ref document number: 962245

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180110

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180110

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20150122

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20221226

Year of fee payment: 9

Ref country code: GB

Payment date: 20221222

Year of fee payment: 9

Ref country code: FR

Payment date: 20221221

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20221226

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20230109

Year of fee payment: 9

Ref country code: ES

Payment date: 20230216

Year of fee payment: 9

Ref country code: DK

Payment date: 20230111

Year of fee payment: 9

Ref country code: CH

Payment date: 20230104

Year of fee payment: 9

Ref country code: AT

Payment date: 20221228

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20221229

Year of fee payment: 9

Ref country code: DE

Payment date: 20221220

Year of fee payment: 9